Source: Journal of Cancer Biology and Clinical Oncology. Unidade: FCF
Subjects: LEUCÓCITOS, PAPILLOMAVIRUS, LEUCÓCITOS, LINFÓCITOS, NEOPLASIAS, FATORES DE RISCO
ABNT
CIANCIARULLO, Marques et al. Human papillomavirus type 16 L1/L2 VLP experimental internalization by human peripheral blood leukocytes. Journal of Cancer Biology and Clinical Oncology, v. 2, n. 2 p. 1-16, 2020Tradução . . Acesso em: 31 ago. 2024.APA
Cianciarullo, M., Szulczewski, V., Sasaki, É. A. K., Hosoda, T. M., Leao, E., Borelli, P., et al. (2020). Human papillomavirus type 16 L1/L2 VLP experimental internalization by human peripheral blood leukocytes. Journal of Cancer Biology and Clinical Oncology, 2( 2 p. 1-16).NLM
Cianciarullo M, Szulczewski V, Sasaki ÉAK, Hosoda TM, Leao E, Borelli P, Boccardo E, Muller M, Karanam B, Becak W. Human papillomavirus type 16 L1/L2 VLP experimental internalization by human peripheral blood leukocytes. Journal of Cancer Biology and Clinical Oncology. 2020 ; 2( 2 p. 1-16):[citado 2024 ago. 31 ]Vancouver
Cianciarullo M, Szulczewski V, Sasaki ÉAK, Hosoda TM, Leao E, Borelli P, Boccardo E, Muller M, Karanam B, Becak W. Human papillomavirus type 16 L1/L2 VLP experimental internalization by human peripheral blood leukocytes. Journal of Cancer Biology and Clinical Oncology. 2020 ; 2( 2 p. 1-16):[citado 2024 ago. 31 ]